Revenue growth accelerated to 17.3% year-over-year in Q2 2026, but gross margin volatility (16.6% in Q2 2026 vs. 8.7% in Q4 2025) and flat operating margin of 8.5% suggest limited operating leverage.
The Ensign Group, Inc. (ENSG) annual income statement — 21-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 |
|---|
| Sales/Revenue | 5.49B | 5.06B | 4.26B | 3.73B | 3.03B | 2.63B | 2.4B | 2.04B | 1.75B | 1.6B | 1.65B | 1.34B | 1.03B | 904.56M | 823.15M | 758.28M | 649.53M | 542M | 469.37M | 411.32M | 358.57M | 300.85M |
| Revenue Growth % | 18.89% | 18.72% | 14.24% | 23.27% | 15.15% | 9.36% | 17.98% | 16.07% | 9.78% | -3.42% | 23.33% | 30.6% | 13.58% | 9.89% | 8.56% | 16.74% | 19.84% | 15.47% | 14.11% | 14.71% | 19.19% | - |
| Cost of Goods Sold | 4.71B | 4.26B | 3.59B | 3.14B | 2.51B | 2.16B | 2B | 1.75B | 1.54B | 1.43B | 1.47B | 1.16B | 871.16M | 739.6M | 669.71M | 614.53M | 531.15M | 449.02M | 391.67M | 351.69M | 301.25M | 255.5M |
| COGS % of Revenue | - | 84.19% | 84.33% | 84.16% | 82.88% | 82.18% | 83.04% | 85.71% | 87.54% | 89.18% | 88.61% | 86.19% | 84.79% | 81.76% | 81.36% | 81.04% | 81.77% | 82.84% | 83.45% | 85.5% | 84.01% | 84.92% |
| Gross Profit | 775.91M | 799.45M | 667.59M | 590.76M | 517.99M | 468.21M | 407.47M | 291.11M | 218.68M | 172.9M | 188.47M | 185.36M | 156.25M | 164.95M | 153.45M | 143.75M | 118.39M | 92.98M | 77.7M | 59.63M | 57.32M | 45.35M |
| Gross Margin % | 14.14% | 15.81% | 15.67% | 15.84% | 17.12% | 17.82% | 16.96% | 14.29% | 12.46% | 10.82% | 11.39% | 13.81% | 15.21% | 18.24% | 18.64% | 18.96% | 18.23% | 17.16% | 16.55% | 14.5% | 15.99% | 15.07% |
| Gross Profit Growth % | - | 19.75% | 13% | 14.05% | 10.63% | 14.91% | 39.97% | 33.12% | 26.48% | -8.26% | 1.68% | 18.63% | -5.28% | 7.5% | 6.75% | 21.42% | 27.32% | 19.67% | 30.3% | 4.02% | 26.39% | - |
| Operating Expenses | 308.52M | 374.15M | 309.28M | 335.39M | 221.16M | 207.75M | 184.31M | 161.93M | 133.76M | 129.71M | 96.62M | 92.27M | 83.33M | 107.01M | 75.18M | 53.05M | 42.73M | 34.04M | 29.04M | 22.91M | 18.43M | 13.37M |
| OpEx % of Revenue | - | 7.4% | 7.26% | 8.99% | 7.31% | 7.91% | 7.67% | 7.95% | 7.62% | 8.12% | 5.84% | 6.88% | 8.11% | 11.83% | 9.13% | 7% | 6.58% | 6.28% | 6.19% | 5.57% | 5.14% | 4.44% |
| Selling, General & Admin | 298.29M | 269.82M | 225.14M | 263M | 158.81M | 151.76M | 129.74M | 110.87M | 90.56M | 74.12M | 69.17M | 64.16M | 56.9M | 40.1M | 31.82M | 29.77M | 26.1M | 20.77M | 20.02M | 15.95M | 14.21M | 10.91M |
| SG&A % of Revenue | - | 5.33% | 5.28% | 7.05% | 5.25% | 5.78% | 5.4% | 5.44% | 5.16% | 4.64% | 4.18% | 4.78% | 5.54% | 4.43% | 3.87% | 3.93% | 4.02% | 3.83% | 4.26% | 3.88% | 3.96% | 3.63% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 2M | 104.33M | 84.14M | 72.39M | 62.35M | 55.98M | 54.57M | 51.05M | 43.2M | 55.59M | 27.46M | 28.11M | 26.43M | 66.91M | 43.36M | 23.29M | 16.63M | 13.28M | 9.03M | 6.97M | 4.22M | 2.46M |
| Operating Income | 467.39M | 425.31M | 358.3M | 255.37M | 296.82M | 260.46M | 223.16M | 129.18M | 84.91M | 43.19M | 91.85M | 93.08M | 72.92M | 57.94M | 78.27M | 90.7M | 75.65M | 58.94M | 48.66M | 36.72M | 38.89M | 31.99M |
| Operating Margin % | 8.52% | 8.41% | 8.41% | 6.85% | 9.81% | 9.91% | 9.29% | 6.34% | 4.84% | 2.7% | 5.55% | 6.94% | 7.1% | 6.41% | 9.51% | 11.96% | 11.65% | 10.87% | 10.37% | 8.93% | 10.85% | 10.63% |
| Operating Income Growth % | - | 18.7% | 40.31% | -13.97% | 13.96% | 16.72% | 72.75% | 52.13% | 96.62% | -52.98% | -1.33% | 27.64% | 25.86% | -25.97% | -13.7% | 19.88% | 28.36% | 21.13% | 32.51% | -5.59% | 21.59% | - |
| EBITDA | 581.95M | 529.63M | 442.44M | 327.75M | 359.18M | 316.45M | 277.73M | 180.23M | 129.78M | 87.66M | 130.53M | 121.19M | 99.35M | 91.88M | 106.74M | 114.7M | 92.29M | 72.21M | 57.79M | 43.7M | 43.11M | 34.44M |
| EBITDA Margin % | 10.61% | 10.47% | 10.38% | 8.79% | 11.87% | 12.04% | 11.56% | 8.85% | 7.4% | 5.48% | 7.89% | 9.03% | 9.67% | 10.16% | 12.97% | 15.13% | 14.21% | 13.32% | 12.31% | 10.62% | 12.02% | 11.45% |
| EBITDA Growth % | 18.92% | 19.71% | 34.99% | -8.75% | 13.5% | 13.94% | 54.09% | 38.88% | 48.05% | -32.84% | 7.7% | 21.98% | 8.13% | -13.92% | -6.94% | 24.29% | 27.8% | 24.96% | 32.26% | 1.35% | 25.17% | - |
| D&A (Non-Cash Add-back) | 114.56M | 104.33M | 84.14M | 72.39M | 62.35M | 55.98M | 54.57M | 51.05M | 44.86M | 44.47M | 38.68M | 28.11M | 26.43M | 33.94M | 28.46M | 24M | 16.63M | 13.28M | 9.14M | 6.98M | 4.22M | 2.46M |
| EBIT | 506.72M | 463.61M | 394.38M | 280.85M | 298.02M | 264.85M | 226.97M | 131.83M | 86.93M | 44.8M | 92.95M | 93.93M | 73.52M | 58.45M | 78.53M | 90.94M | 75.9M | 59.22M | 50.03M | 36.72M | 38.89M | 31.99M |
| Net Interest Income | 15.77M | 16.52M | 20.46M | 11.13M | -3.9M | -2.46M | -5.55M | -13.01M | -13.17M | -12.01M | -6.03M | -1.98M | -12.38M | -12.28M | -11.97M | -13.53M | -8.88M | -5.41M | -3.41M | 0 | 0 | 0 |
| Interest Income | 23.56M | 24.51M | 28.75M | 19.22M | 5.04M | 4.39M | 3.81M | 2.65M | 2.02M | 1.61M | 1.11M | 845K | 594K | 506K | 255K | 249K | 248K | 279K | 1.37M | 0 | 0 | 0 |
| Interest Expense | 7.79M | 7.99M | 8.29M | 8.09M | 8.93M | 6.85M | 9.36M | 15.66M | 15.18M | 13.62M | 7.14M | 2.83M | 12.98M | 12.79M | 12.23M | 13.78M | 9.12M | 5.69M | 4.78M | 0 | 0 | 0 |
| Other Income/Expense | 31.54M | 30.32M | 27.79M | 17.39M | -7.74M | -2.46M | -5.55M | -13.01M | -13.17M | -12.01M | -6.03M | -1.98M | -12.38M | -12.28M | -11.97M | -13.53M | -8.88M | -5.41M | -3.41M | -3.29M | -2.22M | -1.54M |
| Pretax Income | 498.93M | 455.62M | 386.09M | 272.76M | 289.09M | 258M | 217.61M | 116.17M | 71.75M | 31.18M | 85.82M | 91.1M | 60.54M | 45.66M | 66.3M | 77.17M | 66.78M | 53.53M | 45.24M | 33.43M | 36.67M | 30.44M |
| Pretax Margin % | 9.09% | 9.01% | 9.06% | 7.31% | 9.56% | 9.82% | 9.06% | 5.7% | 4.09% | 1.95% | 5.19% | 6.79% | 5.89% | 5.05% | 8.05% | 10.18% | 10.28% | 9.88% | 9.64% | 8.13% | 10.23% | 10.12% |
| Income Tax | 119.89M | 111.36M | 87.64M | 62.91M | 64.44M | 60.28M | 46.24M | 23.95M | 12.69M | 14.21M | 32.98M | 35.18M | 26.8M | 20M | 25.13M | 29.49M | 26.25M | 21.04M | 17.74M | 12.9M | 14.13M | 12.05M |
| Effective Tax Rate % | 24.03% | 24.44% | 22.7% | 23.06% | 22.29% | 23.36% | 21.25% | 20.62% | 17.68% | 45.56% | 38.42% | 38.62% | 44.27% | 43.81% | 37.91% | 38.22% | 39.31% | 39.31% | 39.2% | 38.6% | 38.52% | 39.6% |
| Net Income | 378.7M | 343.97M | 297.97M | 209.4M | 224.68M | 194.65M | 170.48M | 110.53M | 92.36M | 40.48M | 49.99M | 55.43M | 35.95M | 24.04M | 40.59M | 47.67M | 40.53M | 32.49M | 27.51M | 20.53M | 22.55M | 18.39M |
| Net Margin % | 6.9% | 6.8% | 6.99% | 5.61% | 7.43% | 7.41% | 7.1% | 5.43% | 5.26% | 2.53% | 3.02% | 4.13% | 3.5% | 2.66% | 4.93% | 6.29% | 6.24% | 5.99% | 5.86% | 4.99% | 6.29% | 6.11% |
| Net Income Growth % | 17.32% | 15.44% | 42.3% | -6.8% | 15.43% | 14.18% | 54.23% | 19.67% | 128.2% | -19.03% | -9.82% | 54.19% | 49.54% | -40.77% | -14.86% | 17.64% | 24.75% | 18.09% | 34.01% | -8.97% | 22.63% | - |
| Net Income (Continuing) | 378.95M | 344.26M | 298.46M | 209.85M | 224.65M | 197.72M | 171.36M | 92.21M | 59.06M | 16.97M | 52.84M | 55.92M | 33.74M | 25.66M | 41.16M | 47.67M | 40.53M | 32.49M | 27.51M | 20.53M | 22.55M | 18.39M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.84M | 32.87M | 23.7M | 0 | 0 | 0 | 0 | 1.36M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 3.62M | 3.1M | 3.32M | 5.45M | 1.47M | 946K | 150K | 1.95M | 11.4M | 7.66M | 4.05M | -339K | -1.05M | 1.16M | 1.41M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 6.37 | 5.84 | 5.12 | 3.65 | 3.95 | 3.42 | 3.06 | 1.97 | 1.70 | 0.77 | 0.96 | 1.06 | 0.78 | 0.54 | 0.93 | 1.11 | 0.96 | 0.78 | 0.67 | 0.59 | 0.67 | 0.53 |
| EPS Growth % | 15.79% | 14.06% | 40.27% | -7.59% | 15.5% | 11.76% | 55.33% | 15.88% | 120.78% | -19.79% | -9.43% | 35.9% | 44.44% | -41.94% | -16.22% | 15.63% | 23.08% | 16.42% | 13.56% | -11.94% | 26.42% | - |
| EPS (Basic) | - | 6.00 | 5.26 | 3.76 | 4.09 | 3.57 | 3.19 | 2.07 | 1.78 | 0.79 | 0.99 | 1.10 | 0.80 | 0.55 | 0.95 | 1.14 | 0.98 | 0.79 | 0.67 | 0.70 | 0.83 | 0.68 |
| Diluted Shares Outstanding | 59.48M | 58.87M | 58.24M | 57.32M | 56.87M | 56.92M | 55.79M | 55.98M | 54.4M | 52.83M | 52.13M | 52.21M | 46.19M | 44.73M | 43.88M | 43.17M | 42.32M | 41.85M | 41.43M | 34.94M | 33.65M | 35.01M |
| Basic Shares Outstanding | 57.96M | 57.31M | 56.66M | 55.71M | 54.89M | 54.49M | 53.43M | 53.45M | 52.02M | 50.93M | 50.55M | 50.32M | 44.68M | 43.8M | 42.86M | 41.93M | 41.49M | 41.21M | 41.04M | 28.99M | 26.73M | 26.94M |
| Dividend Payout Ratio | - | 4.19% | 4.59% | 6.16% | 5.42% | 5.93% | 6.35% | 9.22% | 10.2% | 21.54% | 16.35% | 13.52% | 17.52% | 17.96% | 16.27% | 9.73% | 10.24% | 11.41% | 11.94% | 12.82% | 8.76% | 6.82% |
Quick answers to the most common questions about buying ENSG stock.
For fiscal year 2025, The Ensign Group, Inc. (ENSG) reported total revenue of $5.06B. This represents a 1581.2% increase compared to $300.9M in 2005.
The Ensign Group, Inc. (ENSG) is profitable, generating $344.0M in net income for the fiscal year ending 2025 with a net profit margin of 6.8%.
The Ensign Group, Inc. (ENSG) reported an operating income of $425.3M, resulting in an operating profit margin of 8.4%. This margin reflects the operational efficiency of the business before interest and taxes.
The Ensign Group, Inc. (ENSG) generated $799.5M in gross profit for the year, representing a gross profit margin of 15.8%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Reimbursement and labor cost pressure
Metrics are mathematically derived from official filings.
Revenue Momentum Persists
Revenue growth accelerated to 17.3% year-over-year in Q2 2026, up from 12.5% in Q2 2024, according to the latest income statement data, indicating sustained acquisition-driven expansion.
The sequential acceleration in revenue growth from 12.5% in Q2 2024 to 17.3% in Q2 2026 suggests that Ensign's buy-and-build strategy continues to contribute meaningfully to the top line. While organic growth may be masked by acquisitions, the consistent upward trend in growth rates implies that the company is successfully integrating new facilities and expanding its footprint. Investors should monitor same-store metrics to isolate organic drivers, but the reported figures point to robust demand for skilled nursing services.
Gross Margin Volatility Raises Flags
Gross margin swung from 16.2% in Q2 2025 to 8.7% in Q4 2025, then recovered to 16.6% in Q2 2026, per reported financials, suggesting significant cost or revenue recognition volatility.
The dramatic drop in gross margin in Q4 2025 to 8.7% appears anomalous, possibly due to one-time charges or a change in revenue mix, but the recovery to 16.6% in Q2 2026 indicates that the underlying margin structure remains intact. However, the volatility warrants scrutiny, as it may reflect the impact of provider taxes or intercompany eliminations that distort quarterly comparisons. The reported gross margin of 13.74% on a TTM basis is well below peers like NHC (67.8%), but this is largely due to the high fixed-cost nature of skilled nursing and the inclusion of pass-through revenues.
Operating Leverage Stalls
Operating income grew only 17.9% year-over-year in Q2 2026, roughly in line with revenue growth of 17.3%, based on reported figures, indicating limited operating leverage despite scale.
While revenue growth has been robust, operating margin has remained relatively flat, hovering around 8.5% to 9.1% over the past year. This suggests that SG&A expenses are scaling proportionally with revenue, possibly due to the decentralized model that requires investment in local leadership and infrastructure. The lack of operating leverage may indicate that Ensign is not yet realizing the full cost synergies from its acquisitions, or that labor costs are absorbing the benefits of scale. Investors should watch for margin expansion as the company matures its clusters.
EPS Growth Outpaces Net Income
Diluted EPS grew 16.7% year-over-year in Q2 2026, while net income grew 18.1%, per the income statement, with stock-based compensation of $16.2M representing a modest 1.1% of revenue.
The quality of earnings appears reasonable, with SBC as a percentage of revenue stable around 1.1% to 1.2% over the past year. However, the Q2 2026 EPS of $1.68 was below the consensus estimate of $1.96, suggesting that reported earnings may be impacted by non-operating items or one-time costs. The tax rate appears consistent, but investors should scrutinize the provision for doubtful accounts and intercompany eliminations, which can distort net income. The raised guidance despite the EPS miss implies management's confidence in future quarters, but the discrepancy warrants monitoring.
Labor Costs Pressure Margins
COGS as a percentage of revenue rose to 83.4% in Q2 2026 from 83.8% in Q2 2025, per reported data, reflecting persistent wage inflation and reliance on contract labor.
The cost structure remains heavily weighted toward labor, which is the primary driver of COGS. The slight improvement in gross margin from 16.2% to 16.6% year-over-year suggests some cost containment, but the overall margin remains thin. SG&A expenses increased 24.3% year-over-year in Q2 2026, outpacing revenue growth, which may indicate investments in corporate infrastructure or acquisition-related costs. Management's expense discipline will be critical to offsetting reimbursement pressures and maintaining profitability.
Margin Compression Risk Looms
Despite revenue growth of 17.3% in Q2 2026, operating margin contracted to 8.5% from 8.5% a year ago, per reported figures, suggesting that top-line expansion is not translating into bottom-line gains.
Short-sellers might argue that Ensign's growth is acquisition-driven and masks underlying margin deterioration. The Q4 2025 gross margin anomaly and the Q2 2026 EPS miss could be early signs of reimbursement pressure or rising labor costs that are not fully offset by scale. Additionally, the company's reliance on Medicare and Medicaid exposes it to regulatory changes, such as minimum staffing mandates, which could significantly increase costs. While the balance sheet is strong, the lack of operating leverage and the potential for margin compression warrant caution.